Porto-sinusoidal vascular liver disorder with portal hypertension: Natural History and Long-Term Outcome.
Marta Magaz,Heloïse Giudicelli-Lett,Juan G. Abraldes,Oana Nicoară-Farcău,Fanny Turon,Neil Rajoriya,Ashish Goel,Karlien Raymenants,Sophie Hillaire,Luis Téllez,Laure Elkrief,Bogdan Procopet,Lara Orts,Filipe Nery,Akash Shukla,Hélène Larrue,Helena Degroote,Victoria Aguilera,Elba LLop,Laura Turco,Federica Indulti,Stefania Gioia,Giulia Tosetti,Niccolò Bitto,Chiara Becchetti,Edilmar Alvarado,Cristina Roig,Raquel Diaz,Michael Praktiknjo,Anna-Lena Konicek,Pol Olivas,José Ignacio Fortea,Helena Masnou,Ángela Puente,Alba Ardèvol,Carmen A. Navascués,Marta Romero-Gutiérrez,Bernhard Scheiner,Georg Semmler,Mattias Mandorfer,Filipe Damião,Anna Baiges,Asunción Ojeda,Macarena Simón-Talero,Carlos González-Alayón,Alba Díaz,Ángeles García-Criado,Andrea De Gottardi,Manuel Hernández-Guerra,Joan Genescà,Nicolas Drilhon,Carlos Noronha Ferreira,Thomas Reiberger,Manuel Rodríguez,Rosa María Morillas,Javier Crespo,Jonel Trebicka,Rafael Bañares,Càndid Villanueva,Annalisa Berzigotti,Massimo Primignani,Vincenzo La Mura,Oliviero Riggio,Filippo Schepis,Xavier Verhelst,José Luis Calleja,Christophe Bureau,Agustín Albillos,Frederik Nevens,Virginia Hernández-Gea,Dhiraj Tripathi,Pierre-Emmanuel Rautou,Juan Carlos García-Pagán,an EASL consortium ERN RARE-LIVER; a study of VALDIG
DOI: https://doi.org/10.1016/j.jhep.2024.07.035
IF: 25.7
2024-08-01
Journal of Hepatology
Abstract:BACKGROUND & AIMS: <AbstractText Label="BACKGROUND &amp; AIMS" NlmCategory="OBJECTIVE">Current knowledge of the natural history of patients with porto-sinusoidal vascular disorder (PSVD) is derived from small studies. The aim of the present study was to determine the natural history of PSVD and prognostic factors in a large multicenter cohort of patients.</AbstractText>METHODS: <AbstractText Label="METHODS" NlmCategory="METHODS">We performed a retrospective study on patients with PSVD and signs of portal hypertension (PH) prospectively registered in 27 centers.</AbstractText>RESULTS: <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 587 patients were included, median age of 47 years and 38% were women. Four-hundred and one patients had an associated condition, which was graded as severe in 157. Median follow-up was 68 months. At diagnosis, 64% of patients were asymptomatic while 36% had a PH-related complication: PH-related bleeding in 112 patients, ascites in 117, and hepatic encephalopathy in 11. In those not presenting with bleeding, the incidence of first bleeding was 15% at 5 years, with a 5-year rebleeding rate of 18%. The 5-year cumulative incidence of new or worsening ascites was 18% and of developing PVT was 16%. Fifty (8.5%) patients received a liver transplantation and 109 (19%) died, including 55 non-liver-related deaths. Transplant-free survival was 97% and 83% at 1 and 5 years, respectively. Variables independently associated with transplant-free survival were age, ascites, serum bilirubin, albumin and creatinine levels at diagnosis and severe associated conditions. This allowed for the creation of a nomogram that accurately predicted prognosis.</AbstractText>CONCLUSIONS: <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The prognosis of PSVD is strongly determined by the severity of the associated underlying conditions and parameters of liver and renal function.</AbstractText>IMPACT AND IMPLICATIONS: <AbstractText Label="IMPACT AND IMPLICATIONS" NlmCategory="UNASSIGNED">Porto-sinusoidal vascular liver disorder (PSVD) is a rare entity that usually affects young people, frequently causes severe complications of portal hypertension, and may reduce life expectancy. To date, there is scarce information regarding its clinical manifestations, natural history and prognostic factors. The present study, including the largest number of patients with PSVD reported so far, shows that overall, when managed at centers of expertise, the prognosis of patients with PSVD is good, with LT-free survival rates of 83% and 72% at 5 and 10 years, respectively. Presence and severity of an underlying associated condition, presence of ascites, age and bilirubin, albumin and creatinine levels were associated with poor prognosis. These results are important to know for hepatologists. A final model combining these parameters enabled development of a nomogram that predicts prognosis with good discrimination and calibration capacity and can be easily applied in clinical practice.</AbstractText>
gastroenterology & hepatology